Security key
00972G207
Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (AKTX)
CUSIP: 00972G207
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Ordinary Shares, $0.000000005 par value
- Total 13F shares
- 304,298
- Total 13F value
- $377,330
- Share change
- -18,485
- SEC-reported price per share
- $1.24
- Number of holders
- 10
- Value change
- -$22,653
- Number of sells
- 5
- Shares outstanding
- 94,284,567,045
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
10
Top holders
10
AKTX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2025
Previous quarter: Q4 2024
Akari Therapeutics Plc SEC filings
Akari Therapeutics Plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 00972G207
Recent filing periods:
Ownership snapshot
Top reported holders of AKTX - Akari Therapeutics Plc - Ordinary Shares, $0.000000005 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Palo Alto Investors LP
Disclosed value leader
Palo Alto Investors LP
Comparable rows
14/15
Latest evidence
20 Mar 2025
13F
3/4/5
Lead comparable stake: 0%
1 rows are not safely comparable across share classes.
Showing 1-6 of 15 holder rows.
Quick read
Palo Alto Investors LP leads the comparable SEC ownership view at 0%.
14 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Palo Alto Investors LP's linked filing trail.
Comparable ownership
Top 5
Palo Alto Investors LP
0%
Omnia Family Wealth, LLC
0%
Cerity Partners LLC
0%
RENAISSANCE TECHNOLOGIES LLC
0%
Cresset Asset Management, LLC
0%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Palo Alto Investors LP |
13F
Company
|
0%
|
$178,149
146,024 shares
|
— | 31 Dec 2024 |
| Omnia Family Wealth, LLC |
13F
Company
|
0%
|
$106,906
87,628 shares
|
— | 31 Dec 2024 |
| Cerity Partners LLC |
13F
Company
|
0%
|
$28,844
23,643 shares
|
— | 31 Dec 2024 |
| RENAISSANCE TECHNOLOGIES LLC |
13F
Company
|
0%
|
$28,627
23,465 shares
|
— | 31 Dec 2024 |
| Cresset Asset Management, LLC |
13F
Company
|
0%
|
$22,458
18,408 shares
|
— | 31 Dec 2024 |
| Catalina Capital Group, LLC |
13F
Company
|
0%
|
$15,988
13,105 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
10
Shares
304,298
Rows available
10
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q4 2024 Across Filers
Q4 2024 holders
14
Q1 2025 holders
10
Holder diff
-4
| Investor | Q4 2024 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q4 2024 value | Q1 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend